Literature DB >> 7153093

Hyperfractionation.

H R Withers, L J Peters, H D Thames, G H Fletcher.   

Abstract

Mesh：

Year:  1982        PMID： 7153093     DOI： 10.1016/0360-3016(82)90307-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  8 in total

1.  Pediatric brainstem glioma. Post-radiation clinical and MR follow-up.

Authors:  R R Smith; R A Zimmerman; R J Packer; D B Hackney; L T Bilaniuk; L N Sutton; H I Goldberg; R I Grossman; L Schut
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

2.  Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study.

Authors:  D S Fulton; R C Urtasun; I Scott-Brown; E S Johnson; B Mielke; B Curry; D Huyser-Wierenga; J Hanson; M Feldstein
Journal:  J Neurooncol       Date:  1992-09       Impact factor: 4.130

3.  [A linear quadratic analysis of the effect of different fractionation patterns on local tumor control: a study on human squamous-cell carcinomas in nude mice].

Authors:  C Petersen; M Baumann; H H Dubben; H Arps; A Melenkeit; J Helfrich
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

4.  Reirradiation of High-Grade Gliomas: A Retrospective Analysis of 198 Patients Based on the Charité Data Set.

Authors:  David Kaul; Vera Pudlitz; Dirk Böhmer; Peter Wust; Volker Budach; Arne Grün
Journal:  Adv Radiat Oncol       Date:  2020-06-18

5.  Hyperfractionated radiotherapy and polychemotherapy in brain stem tumors in children.

Authors:  B Pakisch; C Urban; I Slavc; E Poier; G Stücklschweiger; R Oberbauer; M Mokry; J Poschauko; J Hammer; H Leitner
Journal:  Childs Nerv Syst       Date:  1992-06       Impact factor: 1.475

6.  Hyper-fractionated radiotherapy for soft tissue sarcoma: results of the second study of hyper-fractionated radiotherapy.

Authors:  R Jacob; D Gilligan; M Robinson; C Harmer
Journal:  Sarcoma       Date:  1999

7.  Accelerated hyperfractionation plus temozolomide in glioblastoma.

Authors:  David Kaul; Julian Florange; Harun Badakhshi; Arne Grün; Pirus Ghadjar; Sebastian Exner; Volker Budach
Journal:  Radiat Oncol       Date:  2016-05-21       Impact factor: 3.481

8.  Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis.

Authors:  Rainer J Klement; Ilinca Popp; David Kaul; Felix Ehret; Anca L Grosu; Bülent Polat; Reinhart A Sweeney; Victor Lewitzki
Journal:  J Neurooncol       Date:  2021-12-23       Impact factor: 4.130
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.